CareLit · DOI-Nachweis · Pneumologie
Pirfenidone post-authorization safety registry (PASSPORT) update
DOI 10.1055/s-0036-1572065
Bibliografische Angaben
Nachweis in CareLit
Autor:innenD Koschel, V Cottin, T Maher, A Azuma, LJ Groves, P Hormel, M Sköld, S Tomassetti
ZeitschriftPneumologie
Ausgabe02/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: PASSPORT is a post-authorization safety registry for pirfenidone to collect “real-world” data in EU patients with idiopathic pulmonary fibrosis (IPF). Objectives: 1) Assess the safety of pirfenidone as monotherapy and with N-acetylcysteine (NAC) and/or corticosteroids (CS); 2) examine country-specific differences. Methods: 109 EU sites dosed 1009 patients; largest enrolling countries were Germany (N = 45…
Zitieren
Zitierempfehlung
D Koschel, V Cottin, T Maher, A Azuma, LJ Groves, P Hormel, M Sköld, S Tomassetti (2016) Pirfenidone post-authorization safety registry (PASSPORT) update. Pneumologie (02). https://doi.org/10.1055/s-0036-1572065
Mit CareLit weiterarbeiten